LYOPHILIZED CYTOXAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lyophilized Cytoxan, and what generic alternatives are available?
Lyophilized Cytoxan is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in LYOPHILIZED CYTOXAN is cyclophosphamide. There are nineteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lyophilized Cytoxan
A generic version of LYOPHILIZED CYTOXAN was approved as cyclophosphamide by BAXTER HLTHCARE on May 21st, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LYOPHILIZED CYTOXAN?
- What are the global sales for LYOPHILIZED CYTOXAN?
- What is Average Wholesale Price for LYOPHILIZED CYTOXAN?
Summary for LYOPHILIZED CYTOXAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 95 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,480 |
| DailyMed Link: | LYOPHILIZED CYTOXAN at DailyMed |
Recent Clinical Trials for LYOPHILIZED CYTOXAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Dana-Farber Cancer Institute | Phase 1 |
| Sanofi | Phase 1 |
| Genzyme, a Sanofi Company | Phase 1 |
US Patents and Regulatory Information for LYOPHILIZED CYTOXAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | LYOPHILIZED CYTOXAN | cyclophosphamide | INJECTABLE;INJECTION | 012142-006 | Dec 5, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | LYOPHILIZED CYTOXAN | cyclophosphamide | INJECTABLE;INJECTION | 012142-007 | Dec 10, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LYOPHILIZED CYTOXAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | LYOPHILIZED CYTOXAN | cyclophosphamide | INJECTABLE;INJECTION | 012142-006 | Dec 5, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Baxter Hlthcare | LYOPHILIZED CYTOXAN | cyclophosphamide | INJECTABLE;INJECTION | 012142-007 | Dec 10, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
